Patent Application
Utility
App. No. 16/916,421
· Confirmation No. 6648
FORMULATIONS OF RIFAXIMIN AND USES THEREOF
Applicant:
Salix Pharmaceuticals, Inc.
Abandoned -- Failure to Respond to an Office Action
View Publication ↗
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2023-06-02 | ABN |
Abandonment | 2 | View | |
| 2022-11-28 | N570 |
Communication - Re: Power of Attorney (PTOL-308) | 1 | View | |
| 2022-11-25 | CTNF |
Non-Final Rejection | 16 | View | |
| 2022-11-25 | 892 |
List of references cited by examiner | 1 | View | |
| 2022-11-25 | SRFW |
Search information including classification, databases and other search related notes | 1 | View | |
| 2022-11-25 | BIB |
Bibliographic Data Sheet | 2 | View | |
| 2022-11-25 | SRNT |
Examiner's search strategy and results | 5 | View | |
| 2022-11-25 | 1449 |
List of References cited by applicant and considered by examiner | 12 | View | |
| 2022-11-25 | 1449 |
List of References cited by applicant and considered by examiner | 2 | View | |
| 2022-11-25 | 1449 |
List of References cited by applicant and considered by examiner | 4 | View | |
| 2022-11-25 | SRNT |
Examiner's search strategy and results | 1 | View | |
| 2022-11-25 | 1449 |
List of References cited by applicant and considered by examiner | 5 | View | |
| 2022-11-25 | 1449 |
List of References cited by applicant and considered by examiner | 3 | View | |
| 2022-11-15 | ELC. |
Response to Election / Restriction Filed | 1 | View | |
| 2022-11-15 | CLM |
Claims | 3 | View | |
| 2022-11-15 | REM |
Applicant Arguments/Remarks Made in an Amendment | 1 | View | |
| 2022-11-15 | PA.. |
Power of Attorney | 1 | View | |
| 2022-11-15 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2022-11-15 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2022-09-21 | CTRS |
Requirement for Restriction/Election | 6 | View | |
| 2021-11-02 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 4 | View | |
| 2021-11-02 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 2 | View | |
| 2021-11-02 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2021-11-02 | FOR |
Foreign Reference | 8 | View | |
| 2021-11-02 | FOR |
Foreign Reference | 93 | View | |
| 2020-12-24 | NTC.PUB |
Notice of Publication | 1 | View | |
| 2020-09-15 | APP.FILE.REC |
Filing Receipt | 4 | View | |
| 2020-09-15 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2020-09-11 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 5 | View | |
| 2020-09-11 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 3 | View | |
| 2020-09-11 | N417 |
Electronic Filing System Acknowledgment Receipt | 10 | View | |
| 2020-09-11 | FOR |
Foreign Reference | 47 | View | |
| 2020-09-11 | FOR |
Foreign Reference | 162 | View | |
| 2020-09-11 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 12 | View | |
| 2020-09-11 | PEFR |
Applicant Response to Pre-Exam Formalities Notice | 1 | View | |
| 2020-09-11 | REM |
Applicant Arguments/Remarks Made in an Amendment | 66 | View | |
| 2020-09-11 | SPEC |
Specification | 66 | View | |
| 2020-09-11 | DRW |
Drawings-only black and white line drawings | 32 | View | |
| 2020-09-11 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2020-09-11 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2020-09-11 | A.PE |
Preliminary Amendment | 1 | View | |
| 2020-09-11 | SPEC |
Specification | 1 | View | |
| 2020-09-11 | REM |
Applicant Arguments/Remarks Made in an Amendment | 1 | View | |
| 2020-09-11 | CLM |
Claims | 3 | View | |
| 2020-09-11 | REM |
Applicant Arguments/Remarks Made in an Amendment | 1 | View | |
| 2020-07-13 | NTC.MISS.PRT |
Notice to File Missing Parts | 2 | View | |
| 2020-07-13 | APP.FILE.REC |
Filing Receipt | 4 | View | |
| 2020-07-13 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2020-06-30 | TRNA |
Transmittal of New Application | 1 | View | |
| 2020-06-30 | DRW |
Drawings-only black and white line drawings | 87 | View | |
| 2020-06-30 | OATH |
Oath or Declaration filed | 6 | View | |
| 2020-06-30 | ADS |
Application Data Sheet | 10 | View | |
| 2020-06-30 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2020-06-30 | SPEC |
Specification | 64 | View | |
| 2020-06-30 | CLM |
Claims | 2 | View | |
| 2020-06-30 | ABST |
Abstract | 1 | View |
Inventors
Jon Selbo
West Lafayette, IN
Jing Teng
West Lafayette, IN
Mohammed A. Kabir
Cary, NC
Pam Golden
Durham, NC
Attorneys & Agents of Record
Classification
USPC
424/465
A61K9/10
A61K31/437
A61K47/38
C07D498/22
A61P31/00
A61P31/04
A61P1/00
A61K9/146
A61K9/1641
A61K9/1652
A61K9/2027
A61K9/2054
A61K9/4858
A61K9/4866
A61K47/32
Prosecution
- Examiner
- KASSA, TIGABU
- Art Unit
- 1619
- Customer No.
- 75093
- Docket No.
- 119557-05207
- Confirmation No.
- 6648
Publication
- Pub. No.
- US20200397904A1
- Pub. Date
- 2020-12-24
Parent
is a Continuation of
→
App. 15/615,121
Filed 2017-06-06
· Abandoned -- Failure to Respond to an Office Action
Parent
is a Continuation of
→
App. 14/250,293
· US 9,737,610
Filed 2014-04-10
· Patented Case
Parent
is a Continuation of
→
App. 13/181,481
Filed 2011-07-12
· Abandoned -- Failure to Respond to an Office Action
Parent
Claims priority from a provisional application
→
App. 61/419,056
Filed 2010-12-02
· Provisional Application Expired
Parent
Claims priority from a provisional application
→
App. 61/363,609
Filed 2010-07-12
· Provisional Application Expired
BAUSCH & LOMB INCORPORATED,
BAUSCH HEALTH US, LLC,
SOLTA MEDICAL, INC.,
MEDICIS PHARMACEUTICAL CORPORATION,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD.,
SANTARUS, INC.,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
BAUSCH HEALTH AMERICAS, INC.
RELEASE OF SECURITY INTEREST
Recorded 2025-11-20
SOLTA MEDICAL, INC.,
PRECISION DERMATOLOGY, INC.,
BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED),
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD,
SANTARUS, INC.,
MEDICIS PHARMACEUTICAL CORPORATION,
HUMAX PHARMACEUTICAL S.A.,
SOLTA MEDICAL IRELAND LIMITED,
BAUSCH & LOMB MEXICO, S.A. DE C.V.,
BAUSCH+LOMB OPS B.V.,
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH HEALTH COMPANIES INC.,
BAUSCH HEALTH HOLDCO LIMITED,
BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC),
BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA),
BAUSCH HEALTH US, LLC,
BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.,
ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.),
ORAPHARMA, INC.,
PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.),
SOLTA MEDICAL DUTCH HOLDINGS B.V.,
V-BAC HOLDING CORP.,
VRX HOLDCO LLC,
1261229 B.C. LTD.,
1530065 B.C. LTD.
RELEASE OF SECURITY INTEREST
Recorded 2025-04-08
from
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH HEALTH US, LLC,
MEDICIS PHARMACEUTICAL CORPORATION,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD.,
SANTARUS, INC.,
SOLTA MEDICAL, INC.
SECURITY AGREEMENT (SECOND LIEN)
Recorded 2022-10-05
from
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH HEALTH US, LLC,
MEDICIS PHARMACEUTICAL CORPORATION,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD.,
SANTARUS, INC.,
SOLTA MEDICAL, INC.
SECURITY AGREEMENT (FIRST LIEN)
Recorded 2022-10-04
from
BAUSCH & LOMB INCORPORATED,
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH HEALTH US, LLC,
MEDICIS PHARMACEUTICAL CORPORATION,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD.,
SANTARUS, INC.,
SOLTA MEDICAL, INC.
SECURITY AGREEMENT
Recorded 2022-02-10
from
BAUSCH & LOMB INCORPORATED,
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH HEALTH US, LLC,
MEDICIS PHARMACEUTICAL CORPORATION,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD.,
SANTARUS, INC.,
SOLTA MEDICAL, INC.
SECURITY INTEREST
Recorded 2021-06-08
from
BAUSCH & LOMB INCORPORATED,
BAUSCH HEALTH IRELAND LIMITED,
SALIX PHARMACEUTICALS, INC.,
SOLTA MEDICAL, INC.
SECURITY INTEREST
Recorded 2021-01-21
from
BAUSCH & LOMB INCORPORATED,
BAUSCH HEALTH IRELAND LIMITED,
SALIX PHARMACEUTICALS, INC.,
SOLTA MEDICAL, INC.
SECURITY INTEREST
Recorded 2021-01-21
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2020-09-29
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2020-09-29
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 16/916,421
- Filed
- 2020-06-30
- Pub. No.
- US20200397904A1
- Examiner
- KASSA, TIGABU
- Art Unit
- 1619
External Links